Reinforcing the photocatalytic removal of ibuprofen antibiotic over S-scheme 2D/1D Bi12O17Cl2/V2O5 heterojunction under solar light illumination

Abstract

In our work, the Bi12O17Cl2/V2O5 hybrid with a favorable S-scheme mechanism was prepared via a simple self-assembly procedure for ibuprofen (IBF) oxidation under solar light energy. The 2D Bi12O17Cl2 provides abundant active sites to immobilize 1D V2O5 nanorods, enhancing the interaction between two semiconductors. The establishment of the 2D/1D structure reflected a positive effect on the surface area of Bi12O17Cl2/V2O5-10 %, which was linked to the reduction in the aggregation rate of V2O5 nanorods. Amazingly, optimal Bi12O17Cl2/V2O5 photocatalysts achieved exceptional IBF degradation capacities of 88.6 % and 71.3 % under LED and direct solar light irradiation, respectively. Among the samples, the optimized Bi12O17Cl2/V2O5-10 % reflected the best IBF oxidation kinetic with a reaction constant of 0.03894 min− 1, which is stronger than pristine Bi12O17Cl2 (0.00885 min− 1) and V2O5 (0.0119 min− 1) by 4.4 and 3.27 times, respectively. The promoted catalytic activity was correlated to the S-scheme heterojunction between Bi12O17Cl2 and V2O5 that could upgrade the solar light absorbance, facilitate the separation and transportation of charge carriers, and strengthen the redox potential of Bi12O17Cl2/V2O5. Furthermore, the parameters revealed the best IBF treatment at a catalyst dosage of 0.6 g/L and a pH value of 7. Besides, Bi12O17Cl2/V2O5-10 % recorded outstanding catalytic stability in six cycles without notable alteration in its structure, morphology, or optical properties. On the other hand, the radical quenching tests declared that •O2− and •OH play major contributions in IBF photooxidation over Bi12O17Cl2/V2O5-10 %. Finally, our work offers vital guidance towards designing robust bismuth-based heterojunctions for efficient degradation of IBF antibiotics in a sustainable and cost-effective strategy.